Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 315 entries
Sorted by: Best Match Show Resources per page
Plasticity mechanisms in HfN at elevated and room temperature.

Scientific reports

Vinson K, Yu XX, De Leon N, Weinberger CR, Thompson GB.
PMID: 27708354
Sci Rep. 2016 Oct 06;6:34571. doi: 10.1038/srep34571.

HfN specimens deformed via four-point bend tests at room temperature and at 2300 °C (~0.7 T

Cite
Vinson K, Yu XX, De Leon N, et al. Plasticity mechanisms in HfN at elevated and room temperature. Sci Rep. 2016;6:34571doi: 10.1038/srep34571.
Vinson, K., Yu, X. X., De Leon, N., Weinberger, C. R., & Thompson, G. B. (2016). Plasticity mechanisms in HfN at elevated and room temperature. Scientific reports, 634571. https://doi.org/10.1038/srep34571
Vinson, Katherine, et al. "Plasticity mechanisms in HfN at elevated and room temperature." Scientific reports vol. 6 (2016): 34571. doi: https://doi.org/10.1038/srep34571
Vinson K, Yu XX, De Leon N, Weinberger CR, Thompson GB. Plasticity mechanisms in HfN at elevated and room temperature. Sci Rep. 2016 Oct 06;6:34571. doi: 10.1038/srep34571. PMID: 27708354; PMCID: PMC5052613.
Copy Download .nbib Format: NLM
A cross-sectional study of major repeaters: a distinct phenotype of suicidal behavior.

The primary care companion for CNS disorders

Blasco-Fontecilla H, Jaussent I, Olié E, Béziat S, Guillaume S, Artieda-Urrutia P, Baca-Garcia E, de Leon J, Courtet P.
PMID: 25664212
Prim Care Companion CNS Disord. 2014 Aug 07;16(4). doi: 10.4088/PCC.14m01633. eCollection 2014.

OBJECTIVE: The characterization of major repeaters (individuals with ≥ 5 lifetime suicide attempts) is a neglected area of research. Our aim was to establish whether or not major repeaters are a distinctive suicidal phenotype, taking into account a wide...

Cite
Blasco-Fontecilla H, Jaussent I, Olié E, et al. A cross-sectional study of major repeaters: a distinct phenotype of suicidal behavior. Prim Care Companion CNS Disord. 2014;16(4)doi: 10.4088/PCC.14m01633.
Blasco-Fontecilla, H., Jaussent, I., Olié, E., Béziat, S., Guillaume, S., Artieda-Urrutia, P., Baca-Garcia, E., de Leon, J., & Courtet, P. (2014). A cross-sectional study of major repeaters: a distinct phenotype of suicidal behavior. The primary care companion for CNS disorders, 16(4), . https://doi.org/10.4088/PCC.14m01633
Blasco-Fontecilla, Hilario, et al. "A cross-sectional study of major repeaters: a distinct phenotype of suicidal behavior." The primary care companion for CNS disorders vol. 16,4 (2014). doi: https://doi.org/10.4088/PCC.14m01633
Blasco-Fontecilla H, Jaussent I, Olié E, Béziat S, Guillaume S, Artieda-Urrutia P, Baca-Garcia E, de Leon J, Courtet P. A cross-sectional study of major repeaters: a distinct phenotype of suicidal behavior. Prim Care Companion CNS Disord. 2014 Aug 07;16(4). doi: 10.4088/PCC.14m01633. eCollection 2014. PMID: 25664212; PMCID: PMC4318672.
Copy Download .nbib Format: NLM
Three patients needing high doses of valproic Acid to get therapeutic concentrations.

Case reports in psychiatry

Jackson J, McCollum B, Ognibene J, Diaz FJ, de Leon J.
PMID: 26000191
Case Rep Psychiatry. 2015;2015:542862. doi: 10.1155/2015/542862. Epub 2015 Apr 27.

Valproic acid (VPA) can autoinduce its own metabolism. Cases requiring VPA doses >4000 mg/day to obtain therapeutic plasma concentrations, such as these 3 cases, have never been published. Case 1 received VPA for seizures and schizophrenia and had >50...

Cite
Jackson J, McCollum B, Ognibene J, et al. Three patients needing high doses of valproic Acid to get therapeutic concentrations. Case Rep Psychiatry. 2015;2015:542862doi: 10.1155/2015/542862.
Jackson, J., McCollum, B., Ognibene, J., Diaz, F. J., & de Leon, J. (2015). Three patients needing high doses of valproic Acid to get therapeutic concentrations. Case reports in psychiatry, 2015542862. https://doi.org/10.1155/2015/542862
Jackson, James, et al. "Three patients needing high doses of valproic Acid to get therapeutic concentrations." Case reports in psychiatry vol. 2015 (2015): 542862. doi: https://doi.org/10.1155/2015/542862
Jackson J, McCollum B, Ognibene J, Diaz FJ, de Leon J. Three patients needing high doses of valproic Acid to get therapeutic concentrations. Case Rep Psychiatry. 2015;2015:542862. doi: 10.1155/2015/542862. Epub 2015 Apr 27. PMID: 26000191; PMCID: PMC4427013.
Copy Download .nbib Format: NLM
Future Research and Clinical Directions in the Field of Men's Mental Health: The Madrid Declaration.

Frontiers in public health

Sher L, Rihmer Z, Didia-Attas J, de Leon J, Lin SK, Roncero C, Szerman N, Rice T.
PMID: 25478555
Front Public Health. 2014 Nov 19;2:242. doi: 10.3389/fpubh.2014.00242. eCollection 2014.

No abstract available.

Cite
Sher L, Rihmer Z, Didia-Attas J, et al. Future Research and Clinical Directions in the Field of Men's Mental Health: The Madrid Declaration. Front Public Health. 2014;2:242doi: 10.3389/fpubh.2014.00242.
Sher, L., Rihmer, Z., Didia-Attas, J., de Leon, J., Lin, S. K., Roncero, C., Szerman, N., & Rice, T. (2014). Future Research and Clinical Directions in the Field of Men's Mental Health: The Madrid Declaration. Frontiers in public health, 2242. https://doi.org/10.3389/fpubh.2014.00242
Sher, Leo, et al. "Future Research and Clinical Directions in the Field of Men's Mental Health: The Madrid Declaration." Frontiers in public health vol. 2 (2014): 242. doi: https://doi.org/10.3389/fpubh.2014.00242
Sher L, Rihmer Z, Didia-Attas J, de Leon J, Lin SK, Roncero C, Szerman N, Rice T. Future Research and Clinical Directions in the Field of Men's Mental Health: The Madrid Declaration. Front Public Health. 2014 Nov 19;2:242. doi: 10.3389/fpubh.2014.00242. eCollection 2014. PMID: 25478555; PMCID: PMC4237033.
Copy Download .nbib Format: NLM
On the antibacterial mechanism of graphene oxide (GO) Langmuir-Blodgett films.

Chemical communications (Cambridge, England)

Mangadlao JD, Santos CM, Felipe MJ, de Leon AC, Rodrigues DF, Advincula RC.
PMID: 25582092
Chem Commun (Camb). 2015 Feb 18;51(14):2886-9. doi: 10.1039/c4cc07836e.

The Langmuir-Blodgett (LB) technique was used to immobilize flat graphene oxide (GO) sheets on a PET substrate to ascertain as to whether the edges of GO play an integral part in its antimicrobial mechanism. The observed antibacterial activity suggests...

Cite
Mangadlao JD, Santos CM, Felipe MJ, et al. On the antibacterial mechanism of graphene oxide (GO) Langmuir-Blodgett films. Chem Commun (Camb). 2015;51(14):2886-9doi: 10.1039/c4cc07836e.
Mangadlao, J. D., Santos, C. M., Felipe, M. J., de Leon, A. C., Rodrigues, D. F., & Advincula, R. C. (2015). On the antibacterial mechanism of graphene oxide (GO) Langmuir-Blodgett films. Chemical communications (Cambridge, England), 51(14), 2886-9. https://doi.org/10.1039/c4cc07836e
Mangadlao, J D, et al. "On the antibacterial mechanism of graphene oxide (GO) Langmuir-Blodgett films." Chemical communications (Cambridge, England) vol. 51,14 (2015): 2886-9. doi: https://doi.org/10.1039/c4cc07836e
Mangadlao JD, Santos CM, Felipe MJ, de Leon AC, Rodrigues DF, Advincula RC. On the antibacterial mechanism of graphene oxide (GO) Langmuir-Blodgett films. Chem Commun (Camb). 2015 Feb 18;51(14):2886-9. doi: 10.1039/c4cc07836e. PMID: 25582092.
Copy Download .nbib Format: NLM
Physical Activity, Mediterranean Diet and Biomarkers-Assessed Risk of Alzheimer's: A Multi-Modality Brain Imaging Study.

Advances in molecular imaging

Matthews DC, Davies M, Murray J, Williams S, Tsui WH, Li Y, Andrews RD, Lukic A, McHugh P, Vallabhajosula S, de Leon MJ, Mosconi L.
PMID: 25599008
Adv J Mol Imaging. 2014 Oct;4(4):43-57. doi: 10.4236/ami.2014.44006.

Increased physical activity and higher adherence to a Mediterranean-type diet (MeDi) have been independently associated with reduced risk of Alzheimer's disease (AD). Their association has not been investigated with the use of biomarkers. This study examines whether, among cognitively...

Cite
Matthews DC, Davies M, Murray J, et al. Physical Activity, Mediterranean Diet and Biomarkers-Assessed Risk of Alzheimer's: A Multi-Modality Brain Imaging Study. Adv J Mol Imaging. 2014;4(4):43-57doi: 10.4236/ami.2014.44006.
Matthews, D. C., Davies, M., Murray, J., Williams, S., Tsui, W. H., Li, Y., Andrews, R. D., Lukic, A., McHugh, P., Vallabhajosula, S., de Leon, M. J., & Mosconi, L. (2014). Physical Activity, Mediterranean Diet and Biomarkers-Assessed Risk of Alzheimer's: A Multi-Modality Brain Imaging Study. Advances in molecular imaging, 4(4), 43-57. https://doi.org/10.4236/ami.2014.44006
Matthews, Dawn C, et al. "Physical Activity, Mediterranean Diet and Biomarkers-Assessed Risk of Alzheimer's: A Multi-Modality Brain Imaging Study." Advances in molecular imaging vol. 4,4 (2014): 43-57. doi: https://doi.org/10.4236/ami.2014.44006
Matthews DC, Davies M, Murray J, Williams S, Tsui WH, Li Y, Andrews RD, Lukic A, McHugh P, Vallabhajosula S, de Leon MJ, Mosconi L. Physical Activity, Mediterranean Diet and Biomarkers-Assessed Risk of Alzheimer's: A Multi-Modality Brain Imaging Study. Adv J Mol Imaging. 2014 Oct;4(4):43-57. doi: 10.4236/ami.2014.44006. PMID: 25599008; PMCID: PMC4294269.
Copy Download .nbib Format: NLM
Does parity worsen diabetes-related chronic complications in women with type 1 diabetes?.

World journal of diabetes

Gomes MB, Negrato CA, Almeida A, de Leon AP.
PMID: 27350848
World J Diabetes. 2016 Jun 25;7(12):252-9. doi: 10.4239/wjd.v7.i12.252.

AIM: To determine the relationship between parity, glycemic control, cardiovascular risk factors and diabetes-related chronic complications in women with type 1 diabetes.METHODS: This was a multicenter cross-sectional study conducted between December 2008 and December 2010 in 28 public clinics...

Cite
Gomes MB, Negrato CA, Almeida A, et al. Does parity worsen diabetes-related chronic complications in women with type 1 diabetes?. World J Diabetes. 2016;7(12):252-9doi: 10.4239/wjd.v7.i12.252.
Gomes, M. B., Negrato, C. A., Almeida, A., & de Leon, A. P. (2016). Does parity worsen diabetes-related chronic complications in women with type 1 diabetes?. World journal of diabetes, 7(12), 252-9. https://doi.org/10.4239/wjd.v7.i12.252
Gomes, Marilia Brito, et al. "Does parity worsen diabetes-related chronic complications in women with type 1 diabetes?." World journal of diabetes vol. 7,12 (2016): 252-9. doi: https://doi.org/10.4239/wjd.v7.i12.252
Gomes MB, Negrato CA, Almeida A, de Leon AP. Does parity worsen diabetes-related chronic complications in women with type 1 diabetes?. World J Diabetes. 2016 Jun 25;7(12):252-9. doi: 10.4239/wjd.v7.i12.252. PMID: 27350848; PMCID: PMC4914833.
Copy Download .nbib Format: NLM
Stover Composition in Maize and Sorghum Reveals Remarkable Genetic Variation and Plasticity for Carbohydrate Accumulation.

Frontiers in plant science

Sekhon RS, Breitzman MW, Silva RR, Santoro N, Rooney WL, de Leon N, Kaeppler SM.
PMID: 27375668
Front Plant Sci. 2016 Jun 08;7:822. doi: 10.3389/fpls.2016.00822. eCollection 2016.

Carbohydrates stored in vegetative organs, particularly stems, of grasses are a very important source of energy. We examined carbohydrate accumulation in adult sorghum and maize hybrids with distinct phenology and different end uses (grain, silage, sucrose or sweetness in...

Cite
Sekhon RS, Breitzman MW, Silva RR, et al. Stover Composition in Maize and Sorghum Reveals Remarkable Genetic Variation and Plasticity for Carbohydrate Accumulation. Front Plant Sci. 2016;7:822doi: 10.3389/fpls.2016.00822.
Sekhon, R. S., Breitzman, M. W., Silva, R. R., Santoro, N., Rooney, W. L., de Leon, N., & Kaeppler, S. M. (2016). Stover Composition in Maize and Sorghum Reveals Remarkable Genetic Variation and Plasticity for Carbohydrate Accumulation. Frontiers in plant science, 7822. https://doi.org/10.3389/fpls.2016.00822
Sekhon, Rajandeep S, et al. "Stover Composition in Maize and Sorghum Reveals Remarkable Genetic Variation and Plasticity for Carbohydrate Accumulation." Frontiers in plant science vol. 7 (2016): 822. doi: https://doi.org/10.3389/fpls.2016.00822
Sekhon RS, Breitzman MW, Silva RR, Santoro N, Rooney WL, de Leon N, Kaeppler SM. Stover Composition in Maize and Sorghum Reveals Remarkable Genetic Variation and Plasticity for Carbohydrate Accumulation. Front Plant Sci. 2016 Jun 08;7:822. doi: 10.3389/fpls.2016.00822. eCollection 2016. PMID: 27375668; PMCID: PMC4896940.
Copy Download .nbib Format: NLM
Inorganic-Organic Thiol-ene Coated Mesh for Oil/Water Separation.

ACS applied materials & interfaces

Chen Q, de Leon A, Advincula RC.
PMID: 26236915
ACS Appl Mater Interfaces. 2015 Aug 26;7(33):18566-73. doi: 10.1021/acsami.5b04980. Epub 2015 Aug 12.

A highly efficient mesh for oil/water separation was fabricated by using a superhydrophobic and superoleophilic coating of thiol-ene hybrid, consisting of pentaerythritol tetra(3-mercaptopropionate) (PETMP), 2,4,6,8-tetramethyl-2,4,6,8-tetravinylcyclotetrasiloxane (TMTVSi), and hydrophobic fumed silica nanoparticles, via a simple two-step fabrication process. Spray deposition...

Cite
Chen Q, de Leon A, Advincula RC. Inorganic-Organic Thiol-ene Coated Mesh for Oil/Water Separation. ACS Appl Mater Interfaces. 2015;7(33):18566-73doi: 10.1021/acsami.5b04980.
Chen, Q., de Leon, A., & Advincula, R. C. (2015). Inorganic-Organic Thiol-ene Coated Mesh for Oil/Water Separation. ACS applied materials & interfaces, 7(33), 18566-73. https://doi.org/10.1021/acsami.5b04980
Chen, Qiyi, et al. "Inorganic-Organic Thiol-ene Coated Mesh for Oil/Water Separation." ACS applied materials & interfaces vol. 7,33 (2015): 18566-73. doi: https://doi.org/10.1021/acsami.5b04980
Chen Q, de Leon A, Advincula RC. Inorganic-Organic Thiol-ene Coated Mesh for Oil/Water Separation. ACS Appl Mater Interfaces. 2015 Aug 26;7(33):18566-73. doi: 10.1021/acsami.5b04980. Epub 2015 Aug 12. PMID: 26236915.
Copy Download .nbib Format: NLM
Shift from fibrillar to nonfibrillar Abeta deposits in the neocortex of subjects with Alzheimer disease.

Journal of Alzheimer's disease : JAD

Wegiel J, Bobinski M, Tarnawski M, Dziewiatkowski J, Popovitch E, Bobinski M, Lach B, Reisberg B, Miller DC, De Santi S, De Leon MJ.
PMID: 12214072
J Alzheimers Dis. 2001 Feb;3(1):49-57. doi: 10.3233/jad-2001-3108.

A morphometric study of amyloid-beta-positive plaques in the neocortex of eight non-demented people from 68 to 82 years of age and 17 subjects with late-stage Alzheimer disease (GDS stage 7/FAST stages 7a-f) from 73 to 93 years of age...

Cite
Wegiel J, Bobinski M, Tarnawski M, et al. Shift from fibrillar to nonfibrillar Abeta deposits in the neocortex of subjects with Alzheimer disease. J Alzheimers Dis. 2001;3(1):49-57doi: 10.3233/jad-2001-3108.
Wegiel, J., Bobinski, M., Tarnawski, M., Dziewiatkowski, J., Popovitch, E., Bobinski, M., Lach, B., Reisberg, B., Miller, D. C., De Santi, S., & De Leon, M. J. (2001). Shift from fibrillar to nonfibrillar Abeta deposits in the neocortex of subjects with Alzheimer disease. Journal of Alzheimer's disease : JAD, 3(1), 49-57. https://doi.org/10.3233/jad-2001-3108
Wegiel, Jerzy, et al. "Shift from fibrillar to nonfibrillar Abeta deposits in the neocortex of subjects with Alzheimer disease." Journal of Alzheimer's disease : JAD vol. 3,1 (2001): 49-57. doi: https://doi.org/10.3233/jad-2001-3108
Wegiel J, Bobinski M, Tarnawski M, Dziewiatkowski J, Popovitch E, Bobinski M, Lach B, Reisberg B, Miller DC, De Santi S, De Leon MJ. Shift from fibrillar to nonfibrillar Abeta deposits in the neocortex of subjects with Alzheimer disease. J Alzheimers Dis. 2001 Feb;3(1):49-57. doi: 10.3233/jad-2001-3108. PMID: 12214072.
Copy Download .nbib Format: NLM
[Current status of the treatment of hepatic cirrhosis].

Revista medica de Chile

SEPULVEDA B, DE LEON A.
PMID: 13910719
Rev Med Chil. 1961 Oct;89:729-37.

No abstract available.

Cite
SEPULVEDA B, DE LEON A. [Current status of the treatment of hepatic cirrhosis]. Rev Med Chil. 1961;89:729-37
SEPULVEDA, B., & DE LEON, A. (1961). [Current status of the treatment of hepatic cirrhosis]. Revista medica de Chile, 89729-37.
SEPULVEDA, B, and DE LEON, A. "[Current status of the treatment of hepatic cirrhosis]." Revista medica de Chile vol. 89 (1961): 729-37.
SEPULVEDA B, DE LEON A. [Current status of the treatment of hepatic cirrhosis]. Rev Med Chil. 1961 Oct;89:729-37. Spanish. PMID: 13910719.
Copy Download .nbib Format: NLM
Palonosetron (Aloxi): a second-generation 5-HT₃ receptor antagonist for chemotherapy-induced nausea and vomiting.

Proceedings (Baylor University. Medical Center)

De Leon A.
PMID: 17106506
Proc (Bayl Univ Med Cent). 2006 Oct;19(4):413-6. doi: 10.1080/08998280.2006.11928210.

In July 2003, the Food and Drug Administration approved palonosetron hydrochloride injection for the treatment of chemotherapy-induced nausea and vomiting (CINV). The newest agent in the class of 5-HT₃ receptor antagonists (5-HT₃RAs), palonosetron differs from other agents in its...

Cite
De Leon A. Palonosetron (Aloxi): a second-generation 5-HT₃ receptor antagonist for chemotherapy-induced nausea and vomiting. Proc (Bayl Univ Med Cent). 2006;19(4):413-6doi: 10.1080/08998280.2006.11928210.
De Leon, A. (2006). Palonosetron (Aloxi): a second-generation 5-HT₃ receptor antagonist for chemotherapy-induced nausea and vomiting. Proceedings (Baylor University. Medical Center), 19(4), 413-6. https://doi.org/10.1080/08998280.2006.11928210
De Leon, Andrew. "Palonosetron (Aloxi): a second-generation 5-HT₃ receptor antagonist for chemotherapy-induced nausea and vomiting." Proceedings (Baylor University. Medical Center) vol. 19,4 (2006): 413-6. doi: https://doi.org/10.1080/08998280.2006.11928210
De Leon A. Palonosetron (Aloxi): a second-generation 5-HT₃ receptor antagonist for chemotherapy-induced nausea and vomiting. Proc (Bayl Univ Med Cent). 2006 Oct;19(4):413-6. doi: 10.1080/08998280.2006.11928210. PMID: 17106506; PMCID: PMC1618755.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 315 entries